Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Merck KGaA presents novel PDE7 inhibitors

Aug. 11, 2003

Preliminary PRIMO-CABG results reported

Aug. 7, 2003

CV Therapeutics and FDA agree to cancel Ranexa review

Aug. 6, 2003

Happy Valley Medical licenses Ceracor to Edwards Lifesciences

Aug. 6, 2003

Bayer researchers design adenosine A1 receptor agonists for ischemic disorders

Aug. 5, 2003

Resten-NG continues progress in cardiovascular antisense program

Aug. 1, 2003

Positive phase II results for AC-2592 in CHF

July 31, 2003

Improved pulmonary hypertension in sickle cell disease after oral L-arginine supplementation

July 30, 2003

Diovan approved in Switzerland for ACE inhibitor-intolerant heart failure patients

July 29, 2003

First phase of ONTARGET/TRANSCEND program completed

July 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...